Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-3-10
|
pubmed:abstractText |
Treatment of mature female tilapia (Oreochromis niloticus) with high levels of androgen (17 alpha-methyltestosterone, 17 alpha MT) results in a pronounced decline in plasma vitellogenin levels as determined by gel electrophoresis. Total RNA extracted from livers of treated fish and vehicle-injected controls was analyzed by Northern and slot blot hybridization using an oligonucleotide complementary to a sequence in the 3' end of tilapia vitellogenin mRNA. The probe revealed an mRNA of 6.5 kb in liver from the control mature female fish which was decreased by 85% by androgen treatment. As expected, estradiol (E2) treatment induced the 6.5-kb mRNA in mature male tilapia. The antiestrogen, tamoxifen, strongly decreased vitellogenin mRNA levels in mature females. Radioimmunoassay of serum from control and 17 alpha MT-treated female tilapia showed a marked reduction in serum E2 levels, from 11.4 +/- 2.6 ng/ml in controls to 2.2 +/- 0.13 ng/ml in treated fish. Tamoxifen, however, resulted in increased serum E2 levels, probably by blocking E2 negative feedback. The serum E2-lowering effect of 17 alpha MT suggests an inhibitory site of action on gonadotropin production at the hypothalamic-pituitary axis, possibly through an androgen receptor or through an estrogen receptor after local aromatization of 17 alpha MT.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Methyltestosterone,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Vitellogenins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0016-6480
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8954765-Animals,
pubmed-meshheading:8954765-Binding, Competitive,
pubmed-meshheading:8954765-Blood Proteins,
pubmed-meshheading:8954765-Blotting, Northern,
pubmed-meshheading:8954765-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:8954765-Estradiol,
pubmed-meshheading:8954765-Estrogen Antagonists,
pubmed-meshheading:8954765-Female,
pubmed-meshheading:8954765-Gene Expression,
pubmed-meshheading:8954765-Liver,
pubmed-meshheading:8954765-Male,
pubmed-meshheading:8954765-Methyltestosterone,
pubmed-meshheading:8954765-RNA, Messenger,
pubmed-meshheading:8954765-Receptors, Estrogen,
pubmed-meshheading:8954765-Tamoxifen,
pubmed-meshheading:8954765-Tilapia,
pubmed-meshheading:8954765-Vitellogenins
|
pubmed:year |
1996
|
pubmed:articleTitle |
Androgen inhibition of vitellogenin gene expression in tilapia (Oreochromis niloticus).
|
pubmed:affiliation |
Department of Biochemistry, Dalhousie University, Halifax, Nova Scotia, Canada. CBLAZIE@AC.DAL.CA
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|